A Study of Deflazacort (Emflaza®) in Participants With Duchenne Muscular Dystrophy (DMD)

NCT03642145 · clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Study is no longer necessary given the safety and efficacy of emflaza in this age range has already been established after review of already available data.

Conditions

Interventions

Sponsor

PTC Therapeutics